Axogen discussed Q1 2025 earnings, future outlook

Axogen, Inc. held its Q1 2025 earnings call on Thursday, May 8, 2025, to discuss financial results and provide corporate updates. The call included discussions of financial performance, guidance, and the company's outlook for the year. Key executives, including CEO Michael Dale and CFO Nir Naor, presented the financial results and answered questions from analysts. The call covered topics like revenue, margins, and growth expectations, as well as the biological license application for Avance Nerve Graft. The company also addressed forward-looking statements regarding product launches and market opportunities. A replay of the call is available on Axogen's website for those unable to attend the live event.